Stockreport

AI in Clinical and Molecular Diagnostics Market Research Report 2024-2029: Demand for Personalized Medicine, Software with AI, Untapped Opportunities in Developing Markets Fueling Decelopm...

Koninklijke Philips N.V. NY Registry Shares  (PHG) 
US:NYSE Investor Relations: philips.com/a-w/about/investor.html
PDF The AI in Clinical and Molecular Diagnostics Market was valued at USD 2.6 billion in 2024, and is expected to reach USD 8.9 billion by 2029, rising at a CAGR of 27.60%. [Read more]